The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1, first-in-human, open label, dose escalation ctudy of MGD009, a humanized B7-H3 x CD3 dual-affinity re-targeting (DART) protein in patients with B7-H3-expressing neoplasms or B7-H3 expressing tumor vasculature.
 
Anthony W. Tolcher
Employment - START
Leadership - Symphony Evolution
Consulting or Advisory Role - AbbVie; Akebia Therapeutics; AP Pharma; Aragon Pharmaceuticals; ArQule; Asana Biosciences; Astellas Pharma; Astex Pharmaceuticals; AVID Radiopharmaceuticals; Bayer Schering Pharma; Bind Therapeutics; BioMed Valley Discoveries; Blend Therapeutics; Celator; Clovis Oncology; Curis; Dicerna; Eisai; Emergent BioSolutions; Heron; Janssen; Johnson & Johnson; Lilly; MedImmune; Merck Sharp & Dohme; Mersana; Merus; Nanobiotix; Novartis; Oncogenex; Pfizer; Pharmacyclics; Pierre Fabre; ProNAi; Symphony Evolution; Vaccinex; Valent Technologies; Zyngenia; Zyngenia
 
Evan W. Alley
No Relationships to Disclose
 
Guru Chichili
Employment - Macrogenics
Stock and Other Ownership Interests - Macrogenics
Patents, Royalties, Other Intellectual Property - Our company MacroGenics, Inc holds patents for technology relating to health and medicine.
Travel, Accommodations, Expenses - Macrogenics
 
Jan E. Baughman
Employment - MacroGenics
Stock and Other Ownership Interests - MacroGenics
 
Paul A. Moore
Stock and Other Ownership Interests - GlaxoSmithKline; Medtronic; Teva
Patents, Royalties, Other Intellectual Property - Have patents based on work at MacroGenics, Human Genome Sciences and Celera
 
Ezio Bonvini
Employment - MacroGenics
Leadership - MacroGenics
Stock and Other Ownership Interests - Macrogenics
Research Funding - MacroGenics (Inst)
Patents, Royalties, Other Intellectual Property - Patent application and issued patents held by the US Federal Government (I); Patent applications and issued patents held by MGNX
 
James Robert Vasselli
Employment - Macrogenics; MedImmune
Leadership - Macrogenics; MedImmune
Stock and Other Ownership Interests - Macrogenics; MedImmune
Honoraria - Macrogenics; MedImmune
 
Jon M. Wigginton
Employment - Macrogenics
Leadership - Macrogenics
Stock and Other Ownership Interests - Macrogenics
 
John D. Powderly
Employment - BioCytics; Carolina BioOncology Institute
Leadership - BioCytics; Carolina BioOncology Institute
Stock and Other Ownership Interests - BioCytics; Bluebird Bio; Carolina BioOncology Institute; Juno Therapeutics; Kite, a Gilead company; Lion Biotechnologies; ZIOPHARM Oncology
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Curis; Genentech/Roche; TopAlliance BioSciences Inc
Speakers' Bureau - Bristol-Myers Squibb; Dendreon; Genentech/Roche; Merck
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; EMD Serono; Genentech/Roche; Incyte; Lilly/ImClone; Macrogenics
Patents, Royalties, Other Intellectual Property - BioCytics is developing intellectual property for cellular immunotherapy